DK528386D0 - Proteinabsorptionsforaegende midler - Google Patents

Proteinabsorptionsforaegende midler

Info

Publication number: DK528386D0
Authority: DK; Denmark
Prior art keywords: protein; absorptions; protein absorptions; hydroxylamine; administering
Prior art date: 1985-03-06

Application number

DK528386A

Other languages

English (en)

Other versions

DK528386A (da

Inventor

Stanley Jay Sarnoff

Burton E Sobel

Original Assignee

Survival Technology

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-03-06

Filing date

1986-11-05

Publication date

1986-11-05

1985-03-06 Priority claimed from US06/708,845 external-priority patent/US4661469A/en

1985-10-01 Priority claimed from US06/782,441 external-priority patent/US4772585A/en

1986-11-05 Application filed by Survival Technology filed Critical Survival Technology

1986-11-05 Publication of DK528386D0 publication Critical patent/DK528386D0/da

1986-11-05 Publication of DK528386A publication Critical patent/DK528386A/da

Links

102000004169 proteins and genes Human genes 0.000 title abstract 3
108090000623 proteins and genes Proteins 0.000 title abstract 3
238000010521 absorption reaction Methods 0.000 abstract 2
AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 abstract 1
239000008280 blood Substances 0.000 abstract 1
210000004369 blood Anatomy 0.000 abstract 1
230000002708 enhancing effect Effects 0.000 abstract 1
230000007721 medicinal effect Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Gastroenterology & Hepatology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Biomedical Technology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Dermatology (AREA)
Zoology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

DK528386A 1985-03-06 1986-11-05 Proteinabsorptionsforoegende midler DK528386A (da)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US06/708,845 US4661469A (en)	1984-08-08	1985-03-06	t-PA composition capable of being absorbed into the blood stream and method of administration
US71670585A	1985-03-27	1985-03-27
US06/782,441 US4772585A (en)	1984-08-08	1985-10-01	Protein thrombolytic agent with absorption enhancing agent
PCT/US1986/000475 WO1986005096A1 (en)	1985-03-06	1986-03-06	Protein absorption enhancing agents

Publications (2)

Publication Number	Publication Date
DK528386D0 true DK528386D0 (da)	1986-11-05
DK528386A DK528386A (da)	1986-11-05

Family

ID=27418848

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK528386A DK528386A (da)	1985-03-06	1986-11-05	Proteinabsorptionsforoegende midler

Country Status (9)

Country	Link
EP (1)	EP0214281B1 (da)
AT (1)	ATE80306T1 (da)
AU (1)	AU593794B2 (da)
DE (1)	DE3686684T2 (da)
DK (1)	DK528386A (da)
FI (1)	FI864480L (da)
HU (1)	HUT41632A (da)
NO (1)	NO864382D0 (da)
WO (1)	WO1986005096A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4839170A (en) *	1985-10-01	1989-06-13	Survival Technology, Inc.	Protein absorption enhancing agents
DE3544663A1 (de) *	1985-12-13	1987-06-19	Schering Ag	Thrombosebehandlung mit fibrinolytika und prostacyclinen
DE3729863A1 (de) *	1987-09-05	1989-03-16	Boehringer Mannheim Gmbh	Stabilisierte erythropoietin-lyophilisate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU596356B2 (en) *	1985-04-22	1990-05-03	Genentech Inc.	Novel human tissue plasminogen activator mutants
NO171344C (no) *	1985-05-28	1993-03-03	Wellcome Found	Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende vevsplasminogenaktivator

1986
- 1986-03-06 WO PCT/US1986/000475 patent/WO1986005096A1/en not_active Ceased
- 1986-03-06 FI FI864480A patent/FI864480L/fi not_active Application Discontinuation
- 1986-03-06 EP EP86902132A patent/EP0214281B1/en not_active Expired - Lifetime
- 1986-03-06 HU HU863035A patent/HUT41632A/hu unknown
- 1986-03-06 DE DE8686902132T patent/DE3686684T2/de not_active Expired - Fee Related
- 1986-03-06 AU AU55811/86A patent/AU593794B2/en not_active Ceased
- 1986-03-06 AT AT86902132T patent/ATE80306T1/de not_active IP Right Cessation
- 1986-11-03 NO NO864382A patent/NO864382D0/no unknown
- 1986-11-05 DK DK528386A patent/DK528386A/da not_active Application Discontinuation

Also Published As

Publication number	Publication date
NO864382L (no)	1986-03-11
DE3686684D1 (de)	1992-10-15
EP0214281A4 (en)	1989-03-16
DE3686684T2 (de)	1993-01-28
NO864382D0 (no)	1986-11-03
AU593794B2 (en)	1990-02-22
AU5581186A (en)	1986-09-24
WO1986005096A1 (en)	1986-09-12
HUT41632A (en)	1987-05-28
EP0214281B1 (en)	1992-09-09
FI864480A7 (fi)	1986-11-04
FI864480A0 (fi)	1986-11-04
ATE80306T1 (de)	1992-09-15
EP0214281A1 (en)	1987-03-18
FI864480L (fi)	1986-11-04
DK528386A (da)	1986-11-05

Similar Documents

Publication	Publication Date	Title
DE3587941D1 (de)	1994-12-01	Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen.
NO870241D0 (no)	1987-01-20	Hypoglykemiske tiazolidindioner.
DK614987A (da)	1987-11-23	Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
DK0416678T3 (da)	1993-12-20	Topiske præparater indeholdende Defibrotid
NO893062D0 (no)	1989-07-27	Anvendelse av isokinolinforbindelser, saerlig i inhalasjonspreparater.
NO881904L (no)	1988-11-03	Fremgangsmaate til selektiv immunologisk bestemmelse av intakt prokollagen peptid (type iii) og prokollagen (type iii) i kroppsvaesker, og middel til dets gjennomfoering.
ATE206458T1 (de)	2001-10-15	T-zellen stimulierendes protein von pestivirus
NO864382D0 (no)	1986-11-03	Midler for forbedring av proteinabsorpsjon.
DE68919697D1 (de)	1995-01-12	Katalytische hydrofluorierung von alkenen.
DK513687D0 (da)	1987-09-30	Monoklonale antistoffer over for ifn-omega, fremgangsmaade til deres fremstilling og deres anvendelse til rensning samt paavisning af ifn-omega
IL76121A0 (en)	1985-12-31	Protein absorption enhancing agents
FI885025A0 (fi)	1988-11-01	Koagulationshaemmande protein pp4-x, dess framstaellning och anvaendning.
DK319384A (da)	1985-01-03	1-0-alkyl-3-amino-propan-1,2-diol-2-0-phospholipider, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende disse
FI843695A7 (fi)	1985-03-24	Insuliini-johdannaisia, joissa B 30-asema on modifioitu, menetelmiä niiden valmistamiseksi ja niiden käyttö sekä sokeritaudin hoitoon tarkoitettuja lääkeaineita.
DE3873825D1 (de)	1992-09-24	Die proteinabsorption verbessernde stoffe.
IT1178489B (it)	1987-09-09	Vettore clonante, procedimento per la sua costruzione e procedimento di concentrazione e di purificazione di proteine prodotte, formate dal vettore clonante
ES2052267T3 (es)	1994-07-01	Anticuerpos anti-rh(d) humanos modificados.
IT1246766B (it)	1994-11-26	N-((2-tenoilmercapto-3-metil)-butanoil)-omocisteina tiolattone, sua preparazione e suo uso come agente terapeutico
NO872633D0 (no)	1987-06-23	Monoklonalt antistoff mot humant plasminogen, samt fremstilling derav.
ES522243A0 (es)	1984-08-01	Procedimiento para la preparacion de mezclas de liquidos farmaceuticos,particularmente soluciones de infusion
ATE88359T1 (de)	1993-05-15	Aspirator zur aufnahme von koerperfluessigkeiten.
NO952506L (no)	1995-06-22	Antistoffpreparater mot homogent minaktivin og anvendelse derav for påvisning av minaktivin i humane kroppsvæsker
IT8804860A0 (it)	1988-11-18	Procedimento per il recupero di calore, con eventuale recupero od uso dell'umidita', ceduto direttamente o indirettamente dal corpo umano e dispositivo per la sua attuazione.
BR6802052U (pt)	1990-05-01	Mascara cirurgica descartavel retangular com cadarcos costurados pelo sistema hrow(hight resfst one way)
IT8205203A0 (it)	1982-08-04	Strumento medicale monouso atto per determinare la natura delle affezioni allergiche, tramite cutireazione.

Legal Events

Date	Code	Title	Description
1990-11-26	AHB	Application shelved due to non-payment